RFXAP

regulatory factor X associated protein
OMIM: 601861, ClinGen, DECIPHER

5 panels

Panel Reviews Mode of inheritance Details
5 panels

Green RFXAP in Mendeliome


Version 2.0

2 reviews BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Bare lymphocyte syndrome, type II, complementation group D MIM# 209920
  • Low CD4+ T cells
  • reduced MHC II expression on lymphocytes
  • Normal-low Ig levels
  • Failure to thrive
  • respiratory/gastrointestinal infections
  • liver/biliary tract disease
  • diarrhoea
  • Severe autoimmune cytopaenia
  • agammaglobulinaemia
Tags
  • founder

Green RFXAP in Combined Immunodeficiency


Level 2: Immunological disorders
Version 2.0

1 review BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Melbourne Genomics Health Alliance Immunology Flagship
  • Victorian Clinical Genetics Services
Phenotypes
  • Bare lymphocyte syndrome, type II, complementation group D MIM# 209920
  • Low CD4+ T cells
  • reduced MHC II expression on lymphocytes
  • Normal-low Ig levels
  • Failure to thrive
  • respiratory/gastrointestinal infections
  • liver/biliary tract disease
  • diarrhoea
  • Severe autoimmune cytopaenia
  • agammaglobulinaemia

Green RFXAP in Mackenzie's Mission_Reproductive Carrier Screening


Level 2: Screening
Version 1.0

0 reviews BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Mackenzie's Mission
Phenotypes
  • Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)

Green RFXAP in Prepair 1000+


Level 2: Screening
Version 3.0

1 review BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Mackenzie's Mission
Phenotypes
  • MHC class II deficiency 4 MIM#620817

Green RFXAP in Genomic newborn screening: BabyScreen+


Level 2: Screening
Version 2.0

1 review BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Expert Review
Phenotypes
  • Bare lymphocyte syndrome, type II, complementation group D MIM# 209920
Tags
  • treatable
  • immunological